A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-16-0395

Related search